Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 2.9.2021Mylan Pharmaceuticals Limited (MLB-IE-1)2540AZoledronic acid Mylan 4 mg/5 ml infúzny koncentrát (con inf 1x5 ml/4 mg (liek.inj.skl.))30.9.2021Z
 2.9.2021Mylan Ireland Limited (MNY)0425BEzetimib Mylan 10 mg (tbl 98x10 mg (blis.PVC/Aclar/Al))3.9.2021R
 2.9.2021Mylan Ireland Limited (MNY)0877APerindopril Mylan 4 mg (tbl 30x4 mg (blis.Al/OPA/PVC/Al))3.9.2021R
 2.9.2021Viatris Healthcare Limited (VIM-1)41326Gopten 4 mg (cps 28x4 mg (blis.PVC/PVDC/Al))3.9.2021R
 2.9.2021Mylan IRE Healthcare Limited (MYR)96988Fraxiparine 9 500 IU (anti-Xa)/1 ml (sol inj 10x1 ml/9,5 KU (striek.inj.skl.napl.))3.9.2021R
 2.9.2021Takeda GmbH (TKD-3)13496CONTROLOC 40 mg (tbl ent 28x40 mg (blis.Al/Al so spevn.kartón.obalom))31.8.2021O
 2.9.2021KRKA, d.d., Novo mesto (KRK-2)42603MIRZATEN 30 mg (tbl flm 30x30 mg (blis.PVC/PVDC/Al))30.8.2021O
 2.9.2021KRKA, d.d., Novo mesto (KRK-2)52527Zypsilan 60 mg (cps dur 60x60 mg)18.10.2021R
 31.8.2021Merck Europe B.V. (MCK-NL)28604Cetrotide 0,25 mg prášok a rozpúšťadlo na injekčný roztok (plv iol 7x0,25 mg + 1 ml solv. (liek.inj.skl.+striek.inj.napl.skl.))31.8.2021O
 30.8.2021Recordati Industria Chimica e Farmaceutica S.p.A. (REC-1)46793Eligard 45 mg (plv iol 1x45 mg+1x solv. (striek.inj.napl."A" s PP viečkom+striek.inj.napl."B"+ihla))30.8.2021Z
 30.8.2021Recordati Industria Chimica e Farmaceutica S.p.A. (REC-1)42283Eligard 22,5 mg (plv iol 1x22,5 mg+1x solv. (striek.inj.napl."A"s PP viečkom+striek.inj.napl."B"+ihla))30.8.2021Z
 30.8.2021Recordati Industria Chimica e Farmaceutica S.p.A. (REC-1)42281Eligard 7,5 mg (plv iol 1x7,5 mg+1x solv. (striek.inj.napl."A"s PP viečkom+striek.inj.napl."B"+ihla))30.8.2021Z
 30.8.2021Sandoz Pharmaceuticals d.d. (SAN-SLO-1)0213AAMIRAP 10 mg/5 mg tvrdé kapsuly (cps dur 30x10 mg/5 mg (blis.Al/OPA/Al/PVC))30.8.2021O
 30.8.2021Sandoz Pharmaceuticals d.d. (SAN-SLO-1)0218AAMIRAP 5 mg/5 mg tvrdé kapsuly (cps dur 30x5 mg/5 mg (blis.Al/OPA/Al/PVC))30.8.2021O
 30.8.2021Sandoz Pharmaceuticals d.d. (SAN-SLO-1)14609SANVAL 10 mg (tbl flm 10x10 mg (blis.Al/PVC))30.8.2021O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)